Macarthur Cancer Therapy Centre;
Campbelltown;
NSW 2560;
Australia;
NHMRC Clinical Trials Centre;
Camperdown;
NSW 2050;
Australia;
Department of Medical Oncology;
Royal Melbourne Hospital;
Parkville;
VIC 3052;
Australia;
Melbourne Medical School;
University of Melbourne;
Melbourne;
VIC 3000;
Australia;
Department of Medical Oncology;
Box Hill Hospital;
Box Hill;
VIC 3128;
Australia;
St George Cancer Care Centre;
Kogarah;
NSW 2217;
Australia;
Department of Medical Oncology;
Western Hospital;
Footscray;
VIC 3011;
Australia;
Department of Medical Oncology;
Cabrini Health;
Melbourne;
VIC 3000;
Australia;
Department of Medical Oncology;
the Canberra Hospital;
Garran;
ACT 2605;
Australia;
ANU Medical School;
Australia National University;
Canberra;
ACT 2600;
Australia;
Department of Medical Oncology;
Royal Hobart Hospital;
Hobart;
TAS 7000;
Australia;
Liverpool Cancer Therapy Centre;
Liverpool;
NSW 2170;
Australia;
Department of Medical Oncology;
the Queen Elizabeth Hospital;
Woodville;
SA 5011;
Australia;
Department of Medical Oncology;
Austin Health;
Heidelberg;
VIC 3084;
Australia;
the Kinghorn Cancer Centre;
Garvan Institute of Medical Research;
Darlinghurst;
NSW 2010;
Australia;
Peritoneal; neoplasms; Colorectal; neoplasms; Bevacizumab; Intestinal; perforation; Capecitabine;